An Educational Webinar Series Reviewing the Importance of Comprehensive Genomic Profiling for Patients with Advanced Prostate, Breast, and Lung Cancers

It can be challenging for oncology practices to stay up-to-date with rapidly evolving guidelines for the treatment of patients with advanced prostate, breast, and lung cancers. During this webinar series, we focus on the utilization of Comprehensive Genomic Profiling (CGP) for this group of patients. We review current guidelines pertaining to CGP and biomarker-driven therapies, discuss the differences between genomic and genetic testing, review DNA and RNA testing technologies, discuss the differences between tissue and liquid biopsy based CGP testing and the appropriate time during the patient journey for each, and lastly review how to utilize ctDNA tumor fraction in clinical decision making for the patient with advanced solid cancer and a driver negative liquid biopsy. At the end of this webinar series, participants will have a foundational understanding of how to utilize CGP in the care of their patients with advanced prostate, breast, and lung cancers.                             ON-DEMAND WEBINARS Recorded sessions will be posted below following each live session. If you miss a live session, view it below at your convenience. Check back often for new sessions.

Understanding ctDNA Tumor Fraction in Advanced NSCLC Live event: November 21, 2024 View Recording             Dr. Hatim Husain Thoracic Oncologist                    DNA and RNA sequencing in the Advanced NSCLC Patient Live event: November 11, 2024 View Recording              Dr. Todd Bauer Medical Oncologist                   Why Comprehensive Genomic Profiling (CGP) is Important in Advanced NSCLC Live event: November 5, 2024 View Recording            Dr. Lee Schwartzberg Medical Oncologist                                           Why PTEN Matters in Advanced Breast Cancer  Live event: October 29, 2024 View Recording              Dr. Neal Fischbach Medical Oncologist                   Utilizing Tissue vs. Liquid Comprehensive Genomic Profiling (CGP) in Advanced Breast Cancer  Live event: October 15, 2024 View Recording              Dr. Neal Fischbach Medical Oncologist                   Why Comprehensive Genomic Profiling (CGP) is Important in HR+/HER2- Advanced Breast Cancer Live event: October 10, 2024 View Recording           Dr. Lee Schwartzberg Medical Oncologist                   Germline vs. Somatic Alterations in Advanced Cancers Live event: October 1, 2024 View Recording            Dr. Lee Schwartzberg Medical Oncologist                               Understanding ctDNA Tumor Fraction in Advanced Prostate Cancer Live event: September 24, 2024 View Recording           Dr. Jahan Aghalar, MD Community-Based Oncologist                   Utilizing Tissue versus Liquid Comprehensive Genomic Profiling (CGP) in Advanced Prostate Cancer Live event: September 10, 2024 View Recording           Dr. Jahan Aghalar, MD Community-Based Oncologist                   Why Comprehensive Genomic Profiling (CGP) is Important in Advanced Prostate Cancer Live event: September 4, 2024 View Recording Dr. Scott Sellinger, MD Community Urologist

©2024 Whitehat Communications